Purdue’s Sacklers Ask to Publish Defense to Clear Their Name
Purdue Pharma OxyContin medication
Photographer: George Frey/Bloomberg
This article is for subscribers only.
Purdue Pharma LP’s billionaire owners went on the offensive against what they call unfair press treatment that’s based on the false assumption they helped trigger the U.S. opioid epidemic.
The Sackler family, whose bankrupt company developed the OxyContin painkiller, asked U.S. Bankruptcy Judge Robert Drain in New York on Friday to let it make public a 580-page presentation, outlining its factual and legal defenses, that was shown to Purdue’s creditors on Dec. 6.